DGAP-News
HAEMATO AG: Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR 3.47 million, compared to prior year Q1 period
DGAP-News: HAEMATO AG / Key word(s): Quarter Results
HAEMATO AG: Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100%
to EUR 3.47 million, compared to prior year Q1 period
26.05.2016 / 09:18
The issuer is solely responsible for the content of this announcement.
HAEMATO AG: Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100%
to EUR 3.47 million, compared to prior year Q1 period
26.05.2016 / 09:18
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Corporate News of HAEMATO AG:
Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR
3.47 million, compared to prior year Q1 period
In the first quarter 2016 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved
IFRS Group sales of EUR 69.94 million (prior year period: EUR 45.16
million), an operating result (EBIT) of EUR 3.47 million (prior year
period: EUR 1.67 million) and a net profit of EUR 2.59 million (prior year
period: EUR 1.23 million).
"In the first quarter of 2016 HAEMATO achieved high growth in sales and
profit. We feel well prepared for achievements above prior year periods for
the next quarters in 2016.
Hyaluronic acid and other products for the Lifestyle-Beauty customer
segment in the development process as own HAEMATO products", says Dr.
Christian Pahl, Member of the Management Board of HAEMATO AG.
About HAEMATO:
HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of the
business activities lies on the growth markets of patent free and patent
protected medicinal products. Focal points are therapies with cancer, HIV
and other chronic diseases.
HAEMATO AG is listed in the Entry Standard (Open Market) on the
Frankfurt Stock Exchange. Key figures for the share of HAEMATO AG:
Subscribed capital: EUR 20,778,898
Listed shares: ordinary shares
ISIN: DE000619070
WKN: 619070
Stock symbol: HAE
Contact:
HAEMATO AG, Investor Relations
Telefon: +49 (0)30 897 30 86 70
ir@haemato.de
---------------------------------------------------------------------------
26.05.2016 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
466795 26.05.2016
Corporate News of HAEMATO AG:
Q1 2016: Sales growth 50% to EUR 67.94 million, EBIT-growth 100% to EUR
3.47 million, compared to prior year Q1 period
In the first quarter 2016 HAEMATO AG, Berlin (ISIN: DE0006190705), achieved
IFRS Group sales of EUR 69.94 million (prior year period: EUR 45.16
million), an operating result (EBIT) of EUR 3.47 million (prior year
period: EUR 1.67 million) and a net profit of EUR 2.59 million (prior year
period: EUR 1.23 million).
"In the first quarter of 2016 HAEMATO achieved high growth in sales and
profit. We feel well prepared for achievements above prior year periods for
the next quarters in 2016.
Hyaluronic acid and other products for the Lifestyle-Beauty customer
segment in the development process as own HAEMATO products", says Dr.
Christian Pahl, Member of the Management Board of HAEMATO AG.
About HAEMATO:
HAEMATO AG, founded in 1993, is a pharmaceutical company. The focus of the
business activities lies on the growth markets of patent free and patent
protected medicinal products. Focal points are therapies with cancer, HIV
and other chronic diseases.
HAEMATO AG is listed in the Entry Standard (Open Market) on the
Frankfurt Stock Exchange. Key figures for the share of HAEMATO AG:
Subscribed capital: EUR 20,778,898
Listed shares: ordinary shares
ISIN: DE000619070
WKN: 619070
Stock symbol: HAE
Contact:
HAEMATO AG, Investor Relations
Telefon: +49 (0)30 897 30 86 70
ir@haemato.de
---------------------------------------------------------------------------
26.05.2016 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
466795 26.05.2016
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte